Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.

Inhibiting the herpes simplex virus type 1 viral enzyme uracil-DNA glycosylase reactivates the natural defense protein apolipoprotein B mRNA editing enzyme, catalytic polypeptide-1 (APOBEC1) in the ...

Around one in every five people aged below 50 around the world is infected with incurable genital herpes, researchers have newly estimated. According to a new paper in the journal Sexually Transmitted ...

Genital herpes infections are very common. There are 42 million new infections each year — that averages out to one new person infected each second. While treatments can help with symptoms, there's no ...

Megan Molteni reports on discoveries from the frontiers of genomic medicine, neuroscience, and reproductive tech. She joined STAT in 2021 after covering health and science at WIRED. You can reach ...